Newron Pharmaceuticals SpA (XSWX:NWRN) 3-Year Revenue Growth Rate

: 14.60% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

Newron Pharmaceuticals SpA's Revenue per Share for the six months ended in Dec. 2023 was CHF0.19.

During the past 12 months, Newron Pharmaceuticals SpA's average Revenue per Share Growth Rate was 42.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Newron Pharmaceuticals SpA was 86.60% per year. The lowest was -53.00% per year. And the median was 7.00% per year.

Competitive Comparison

For the Biotechnology subindustry, Newron Pharmaceuticals SpA's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newron Pharmaceuticals SpA 3-Year Revenue Growth Rate Distribution

For the Biotechnology industry and Healthcare sector, Newron Pharmaceuticals SpA's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Newron Pharmaceuticals SpA's 3-Year Revenue Growth Rate falls into.

Newron Pharmaceuticals SpA 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Newron Pharmaceuticals SpA (XSWX:NWRN) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Newron Pharmaceuticals SpA 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA (XSWX:NWRN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

NWPHF:USA NP5:Germany

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Executives

Patrick Langlois

Supervisory Board

Newron Pharmaceuticals SpA (XSWX:NWRN) Headlines

No Headlines